Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationStem CellsHematopoietic Stem Cell MobilizationTransplantation ConditioningHematopoietic Stem CellsBone Marrow TransplantationCord Blood Stem Cell TransplantationGraft vs Host DiseaseHematologic NeoplasmsGranulocyte Colony-Stimulating FactorLiver TransplantationLeukapheresisGraft SurvivalBlood CellsAntigens, CD34Blood Component RemovalTreatment OutcomeTissue DonorsTransplantation ChimeraMelphalanKidney TransplantationCombined Modality TherapyCell TransplantationEmbryonic Stem CellsBusulfanMultiple MyelomaCyclophosphamideMesenchymal Stem Cell TransplantationAdult Stem CellsMyeloablative AgonistsBlood Cell CountRecurrenceWhole-Body IrradiationHistocompatibility TestingCell DifferentiationTime FactorsImmunosuppressive AgentsAntineoplastic Combined Chemotherapy ProtocolsHistocompatibilityHematopoiesisLeukocytes, MononuclearRemission InductionRetrospective StudiesHeart TransplantationFetal BloodPluripotent Stem CellsLeukemiaCells, CulturedFlow CytometryLymphoma, Non-HodgkinLung TransplantationTransplantation ImmunologyTransplantation, IsogeneicBone Marrow CellsStem Cell NicheSurvival RateT-LymphocytesVidarabineNeural Stem CellsDisease-Free SurvivalCell SeparationSurvival AnalysisEtoposideLeukocyte CountInduced Pluripotent Stem CellsGraft RejectionAntineoplastic Agents, AlkylatingLeukemia, Myeloid, AcuteBone MarrowStem Cell FactorThiotepaMesenchymal Stromal CellsCell LineageOrgan TransplantationSalvage TherapyHematologic DiseasesFollow-Up StudiesInfectionMultipotent Stem CellsLymphocytesImmunophenotypingGraft vs Leukemia EffectAntigens, CDColony-Forming Units AssayIslets of Langerhans TransplantationImmunosuppressionAnemia, AplasticHLA AntigensHodgkin DiseaseCytarabineTransplantationMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePlatelet CountLymphocyte DepletionBone Marrow Purging